iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025

There are a number of guidelines on how to manage obesity, but inconsistencies in healthcare access, varying infrastructure, resource constraints and diverse local practices restrict their global applicability. This underscores the need for universal recommendations that address the unique challenges faced by patients and healthcare providers worldwide. Our Global Guidelines emphasise the incorporation of novel therapies while integrating standards of care with the most up-to-date evidence to enable clinicians to optimise obesity management. Context-specific recommendations tailored to individual patient needs are highlighted, providing a thorough evaluation of the risks, benefits and overall value of each therapy, aiming to establish a standard of care that improves patient outcomes and reduces the burden of hospitalisation in this susceptible population. These Global Guidelines provide evidence-based recommendations that represent a group consensus considering the many other published guidelines that have reviewed many of the issues discussed here, but they also make new recommendations where new evidence has recently emerged, and-most importantly-also provide recommendations on several issues where resource limitations may put constraints on the care provided to patients living with obesity. Such 'economic adjustment' recommendations aim to guide situations when 'Resources are somewhat limited' or when 'Resources are severely limited'. Hence, this document presents a comprehensive update to obesity management guidelines, thereby aiming to provide a unified strategy for the pharmacological, non-pharmacological and invasive management of this significant global health challenge that is applicable to the needs of healthcare around the globe.

Authors

Publication Details

Journal
Journal of Cachexia Sarcopenia and Muscle
Published
2026-02-01
DOI
https://doi.org/10.1002/jcsm.70167
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025

Sameh Shaheen, Dike Bevis Ojji, Andréa Araújo Brandão, Anastase Dzudié et al.
Journal of Cachexia Sarcopenia and Muscle
Pharmacology and Obesity Treatment
article

iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025

Sameh Shaheen, Dike Bevis Ojji, Andréa Araújo Brandão, Anastase Dzudié, Uday Jadhav, Ahmed Bennis, Martha Gulati, Amit Saraf, Walter P. Abhayaratna, Raquel Cayón Campuzano, John James Atherton, Tammy L. Kindel, Steven R. Jones, Hani Sabbour, Shelley R. Zieroth, Danielle Belardo, Clemencia de Rueda Panadero, Yuan‐Lin Guo, Shaaf Ahmad, Wael Al Mahmeed, Fernando Wyss, Hidetaka Itoh, Karol Watson, Geeta Appannah, Alison L. Bailey, Stefan D. Anker, Adriana Puente Barragán, Emilio S. Peralta Lopez, Abraham Oomman, Yuri Lopatin, Nandini Chatterjee, Zhiyi Ma, Shariq Usman, Julie Redfern, Alessia Argirò, Peter Rossing, Ping Li, Andrew J. S. Coats, Fausto J. Pinto, Kamlesh K. Khunti, William T. Abraham, Javed Butler, Subodh Verma, Mangesh Tiwaskar, Paul Poirier, Julio Rosenstock, Sarah Davies, Jose Luis Zamorano, Kwang Wei Tham, Banshi Saboo, Donna Ryan, Naveed Sattar, Muhammad Arsalan Abid Khan, Carel W. Le Roux, Marc‐André Cornier, Melanie J. Davies, Linong Ji
article en

Abstract

There are a number of guidelines on how to manage obesity, but inconsistencies in healthcare access, varying infrastructure, resource constraints and diverse local practices restrict their global applicability. This underscores the need for universal recommendations that address the unique challenges faced by patients and healthcare providers worldwide. Our Global Guidelines emphasise the incorporation of novel therapies while integrating standards of care with the most up-to-date evidence to enable clinicians to optimise obesity management. Context-specific recommendations tailored to individual patient needs are highlighted, providing a thorough evaluation of the risks, benefits and overall value of each therapy, aiming to establish a standard of care that improves patient outcomes and reduces the burden of hospitalisation in this susceptible population. These Global Guidelines provide evidence-based recommendations that represent a group consensus considering the many other published guidelines that have reviewed many of the issues discussed here, but they also make new recommendations where new evidence has recently emerged, and-most importantly-also provide recommendations on several issues where resource limitations may put constraints on the care provided to patients living with obesity. Such 'economic adjustment' recommendations aim to guide situations when 'Resources are somewhat limited' or when 'Resources are severely limited'. Hence, this document presents a comprehensive update to obesity management guidelines, thereby aiming to provide a unified strategy for the pharmacological, non-pharmacological and invasive management of this significant global health challenge that is applicable to the needs of healthcare around the globe.

Journal of Cachexia Sarcopenia and MuscleVol. 17(1)
Industry, innovation and infrastructure
Openalex Percentile: Top 56%
Pharmacology and Obesity Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.